Trade PDS Biotechnology Corporation - PDSB CFD
Add to favourite- Summary
- Historical Data
Spread | 0.06 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 3.92 |
Open | 3.92 |
1-Year Change | -25.05% |
Day's Range | 3.81 - 3.98 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Jul 25, 2024 | 3.92 | 0.11 | 2.89% | 3.81 | 3.98 | 3.71 |
Jul 24, 2024 | 3.74 | -0.34 | -8.33% | 4.08 | 4.17 | 3.72 |
Jul 23, 2024 | 4.19 | 0.31 | 7.99% | 3.88 | 4.28 | 3.81 |
Jul 22, 2024 | 3.87 | 0.02 | 0.52% | 3.85 | 3.90 | 3.70 |
Jul 19, 2024 | 3.85 | 0.07 | 1.85% | 3.78 | 3.95 | 3.74 |
Jul 18, 2024 | 3.84 | -0.07 | -1.79% | 3.91 | 4.08 | 3.75 |
Jul 17, 2024 | 3.99 | -0.05 | -1.24% | 4.04 | 4.25 | 3.89 |
Jul 16, 2024 | 4.12 | -0.12 | -2.83% | 4.24 | 4.39 | 4.00 |
Jul 15, 2024 | 4.20 | 0.12 | 2.94% | 4.08 | 4.37 | 4.07 |
Jul 12, 2024 | 4.07 | 0.17 | 4.36% | 3.90 | 4.24 | 3.90 |
Jul 11, 2024 | 3.84 | 0.30 | 8.47% | 3.54 | 3.97 | 3.53 |
Jul 10, 2024 | 3.50 | 0.14 | 4.17% | 3.36 | 3.61 | 3.36 |
Jul 9, 2024 | 3.35 | 0.22 | 7.03% | 3.13 | 3.49 | 3.13 |
Jul 8, 2024 | 3.21 | 0.19 | 6.29% | 3.02 | 3.29 | 2.99 |
Jul 5, 2024 | 3.10 | 0.18 | 6.16% | 2.92 | 3.12 | 2.92 |
Jul 3, 2024 | 2.98 | 0.05 | 1.71% | 2.93 | 3.10 | 2.88 |
Jul 2, 2024 | 2.93 | -0.02 | -0.68% | 2.95 | 2.98 | 2.78 |
Jul 1, 2024 | 3.00 | 0.11 | 3.81% | 2.89 | 3.04 | 2.89 |
Jun 28, 2024 | 2.90 | -0.10 | -3.33% | 3.00 | 3.01 | 2.88 |
Jun 27, 2024 | 2.96 | 0.03 | 1.02% | 2.93 | 3.12 | 2.93 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
PDS Biotechnology Corporation Company profile
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies, and cervical cancer. The company is also developing various product candidates, which are in preclinical trials, including PDS0102 T-cell receptor gamma alternate reading frame protein (TARP) for treating prostate and breast cancers; PDS0103 (MUC-1) for ovarian, colorectal, lung, and breast cancers; and PDS0104, which include Tyrosinase-related protein 2 for the treatment of melanoma. In addition, it is developing PDS0201 for treating tuberculosis; PDS0202, an influenza vaccine candidate; and PDS0203, a vaccine for the prevention of COVID-19. The company has a license and collaboration agreements with National Institutes of Health, Merck Eprova AG, The U.S. Department of Health and Human Services, and MSD International GmbH. PDS Biotechnology Corporation was founded in 2005 and is based in Florham Park, New Jersey.Industry: | Bio Therapeutic Drugs |
303A College Road East
PRINCETON
NEW JERSEY 08540
US
News
![](https://img.capital.com/imgs/articles/192x130x1/Risk-Management-in-Trading.png)
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ECB_0.png)
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024![](https://img.capital.com/imgs/articles/192x130x1/risk_2_1_optimized_450_1.png)
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024![](https://img.capital.com/imgs/articles/192x130x1/Stock-1-_1.png)
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024![](https://img.capital.com/imgs/articles/192x130x1/ETF-1-_0.png)
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024![Lloyds share price forecast: An attractive dividend stock? Lloyds share price forecast: An attractive dividend stock?](https://img.capital.com/imgs/articles/192x130x1/shutterstock_536730610_0.jpg)
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024![](https://img.capital.com/imgs/articles/192x130x1/RBNZ.png)
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com